Join
Live feed
·
INSIDERFilingvia Quantisnow
Interpace Biosciences, Inc. logo

Chief Financial Officer Mccarthy Christopher converted options into 38,475 shares, increasing direct ownership by 463% to 46,791 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
IDXG· Interpace Biosciences, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IDXG (Interpace Biosciences, Inc.) and more on Quantisnow.